News related to Erbitux (Cetuximab) and/or conditions it is approved for
European Commission approves update of Erbitux metastatic colorectal cancer labeling to patients with RAS wild-type tumors
Source: Colorectal Cancer News From Medical News Today [2013.12.24]
Merck Serono, the biopharmaceutical division of Merck, has announced that the European Commission has approved the Type II variation to amend the Erbitux® (cetuximab) product information, updating the indication for Erbitux to the treatment of patients with RAS wild-type metastatic colorectal cancer (mCRC).
Colorectal cancer: the risk factors, symptoms and importance of screening
Source: Cancer / Oncology News From Medical News Today [2014.03.05]
According to the American Cancer Society, the lifetime risk of developing colorectal cancer is around 1 in 20. But according to a recent report from the Centers for Disease Control and Prevention, there are more than 20 million adults in the US who have never had the recommended screening for the disease, putting them at higher risk of dying from a preventable condition.
Gut microbes may play a role in colorectal cancer
Source: Colorectal Cancer News From Medical News Today [2014.03.04]
New research from the US suggests an individual's particular mix of gut microbes may help the development of colorectal cancer tumors by interacting with genes and inflammatory responses.Colorectal cancer happens because healthy cells in the gut start to behave oddly following changes or mutations in their genes.
Stomach and colorectal cancers may be treatable with existing drug
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.02.05]
A class of drugs already used to treat a blood disorder could be used to treat stomach and colorectal cancer, according to new research from Australia.Called JAK inhibitors, the drugs are currently used to treat a cancer-like condition called myelofibrosis.
Simple, at-home test will detect most colorectal cancers
Source: Colorectal Cancer News From Medical News Today [2014.02.03]
Tests that require patients to collect a single stool sample at home and then send it to a lab for analysis will detect about 79 percent of colorectal cancers, according to a new evidence review published in the Annals of Internal Medicine.
Follow-up tests improve colorectal cancer recurrence detection
Source: Colorectal Cancer News From Medical News Today [2014.01.14]
Among patients who had undergone curative surgery for primary colorectal cancer, the screening methods of computed tomography and carcinoembryonic antigen each provided an improved rate of surgical treatment of cancer recurrence compared with minimal follow-up, although there was no advantage in combining these tests, according to a study in the January 15 issue of JAMA.
Online colorectal cancer risk calculator created
Source: Colorectal Cancer News From Medical News Today [2014.01.07]
Researchers at Cleveland Clinic have developed a new tool called CRC-PRO that allows physicians to quickly and accurately predict an individual's risk of colorectal cancer, as published in the current edition of the Journal of the American Board of Family Medicine.
Colorectal Cancer Pictures Slideshow: Understanding Cancer of the Colon
Source: MedicineNet Rectal Bleeding Specialty [2013.06.07]
Title: Colorectal Cancer Pictures Slideshow: Understanding Cancer of the Colon
Created: 9/21/2009 12:59:00 PM
Last Editorial Review: 6/7/2013 12:00:00 AM
Antidepressants might reduce risk of colorectal cancer
Source: The Doctors Lounge - Psychiatry
Use of serotonin reuptake inhibitors (SSRI) might inhibit the growth of colorectal tumors according to The Lancet Oncology.
Many mCRC Patients in the US Not Getting Optimal Treatment
Source: Medscape General Surgery Headlines [2014.03.07]
A study of chemotherapy usage patterns for patients with metastatic colorectal cancer (mCRC) in the United States concludes that many are not being treated according to current NCCN guidelines.
Medscape Medical News
Cancer Screening Rates Fall Below CDC Target Goals
Source: Medscape Gastroenterology Headlines [2014.03.05]
Breast and cervical cancer screening rates have declined and colorectal cancer screening has gone up, but all fall short of Healthy People 2020 targets.
Medscape Medical News
Improvements in colon cancer survival largely reflect gains among non-elderly whites and Asians
Source: Colorectal Cancer News From Medical News Today [2014.02.18]
While new and better treatments have improved the odds of survival for patients diagnosed with late stage colorectal cancer, that progress has been largely confined to non-Hispanic whites and Asians and those under age 65, according to a new study. American Cancer Society researchers led by Helmneh Sineshaw, M.D.
Regorafenib: hint of minor added benefit
Source: Colorectal Cancer News From Medical News Today [2014.01.15]
Advantage in overall survival, but disadvantage in severe side effectsRegorafenib (trade name: Stivarga) has been approved in Germany since August 2013 for adults with metastatic colorectal cancer in whom previous treatments are no longer effective or for whom these alternatives are not an option.